These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 26272764)

  • 1. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy.
    Jia HZ; Zhang W; Zhu JY; Yang B; Chen S; Chen G; Zhao YF; Feng J; Zhang XZ
    J Control Release; 2015 Oct; 216():9-17. PubMed ID: 26272764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy.
    Wu M; Liu X; Jin W; Li Y; Li Y; Hu Q; Chu PK; Tang G; Ping Y
    J Control Release; 2017 May; 253():110-121. PubMed ID: 28302581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
    Han L; Tang C; Yin C
    Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric assembly of hyperbranched building blocks to establish tunable nanoplatforms for lysosome acidity-responsive gene/drug co-delivery.
    Jia HZ; Zhang W; Wang XL; Yang B; Chen WH; Chen S; Chen G; Zhao YF; Zhuo RX; Feng J; Zhang XZ
    Biomater Sci; 2015 Jul; 3(7):1066-77. PubMed ID: 26221940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M; Li J; Lin X; Wei Z; Zhang D; Zhao B; Liu X; Liu J
    Biomater Sci; 2018 May; 6(6):1457-1468. PubMed ID: 29770812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy.
    Chen W; Yuan Y; Cheng D; Chen J; Wang L; Shuai X
    Small; 2014 Jul; 10(13):2678-87. PubMed ID: 24668891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular structural transformation regulated dynamic disordering of supramolecular vesicles as pH-responsive drug release systems.
    Liu Y; Gao FP; Zhang D; Fan YS; Chen XG; Wang H
    J Control Release; 2014 Jan; 173():140-7. PubMed ID: 24188958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.
    Cheng D; Cao N; Chen J; Yu X; Shuai X
    Biomaterials; 2012 Feb; 33(4):1170-9. PubMed ID: 22061491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel.
    Zhang P; Wang C; Zhao J; Xiao A; Shen Q; Li L; Li J; Zhang J; Min Q; Chen J; Chen HY; Zhu JJ
    ACS Nano; 2016 Mar; 10(3):3637-47. PubMed ID: 26905935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z; Zhang L; Tang C; Yin C
    Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A boronate-linked linear-hyperbranched polymeric nanovehicle for pH-dependent tumor-targeted drug delivery.
    Jia HZ; Zhu JY; Wang XL; Cheng H; Chen G; Zhao YF; Zeng X; Feng J; Zhang XZ; Zhuo RX
    Biomaterials; 2014 Jun; 35(19):5240-9. PubMed ID: 24698522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
    El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
    Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient nuclear drug translocation and improved drug efficacy mediated by acidity-responsive boronate-linked dextran/cholesterol nanoassembly.
    Zhu JY; Lei Q; Yang B; Jia HZ; Qiu WX; Wang X; Zeng X; Zhuo RX; Feng J; Zhang XZ
    Biomaterials; 2015 Jun; 52():281-90. PubMed ID: 25818434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
    Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
    J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment.
    Gong C; Hu C; Gu F; Xia Q; Yao C; Zhang L; Qiang L; Gao S; Gao Y
    J Control Release; 2017 Nov; 266():272-286. PubMed ID: 28987884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.